Steigerwald Gordon & Koch Inc. Purchases New Position in Revvity, Inc. (NYSE:RVTY)

Steigerwald Gordon & Koch Inc. purchased a new stake in shares of Revvity, Inc. (NYSE:RVTYFree Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 117,369 shares of the company’s stock, valued at approximately $12,830,000. Steigerwald Gordon & Koch Inc. owned 0.10% of Revvity at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of RVTY. Raymond James Financial Services Advisors Inc. purchased a new stake in Revvity in the fourth quarter worth about $529,000. Raymond James & Associates purchased a new stake in Revvity in the fourth quarter worth about $869,000. JTC Employer Solutions Trustee Ltd purchased a new stake in Revvity in the fourth quarter worth about $33,000. SG Americas Securities LLC purchased a new stake in Revvity in the fourth quarter worth about $10,223,000. Finally, CX Institutional purchased a new stake in Revvity in the fourth quarter worth about $867,000. Hedge funds and other institutional investors own 86.65% of the company’s stock.

Revvity Stock Down 0.2 %

Shares of Revvity stock opened at $103.00 on Tuesday. The company has a market cap of $12.72 billion, a price-to-earnings ratio of 18.73, a price-to-earnings-growth ratio of 2.69 and a beta of 1.10. The company’s 50 day moving average is $105.90 and its 200 day moving average is $102.36. Revvity, Inc. has a twelve month low of $79.50 and a twelve month high of $139.04. The company has a quick ratio of 1.77, a current ratio of 2.07 and a debt-to-equity ratio of 0.40.

Revvity (NYSE:RVTYGet Free Report) last issued its quarterly earnings data on Thursday, February 1st. The company reported $1.25 earnings per share for the quarter, beating analysts’ consensus estimates of $1.15 by $0.10. Revvity had a net margin of 25.20% and a return on equity of 7.41%. The company had revenue of $695.90 million for the quarter. Research analysts anticipate that Revvity, Inc. will post 4.65 EPS for the current year.

Revvity Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Friday, April 19th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Thursday, April 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.27%. Revvity’s dividend payout ratio is currently 5.09%.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the stock. KeyCorp upped their price objective on shares of Revvity from $110.00 to $126.00 and gave the stock an “overweight” rating in a report on Friday, February 2nd. Raymond James upped their price objective on shares of Revvity from $106.00 to $127.00 and gave the stock an “outperform” rating in a report on Friday, February 2nd. Wolfe Research began coverage on shares of Revvity in a research note on Wednesday, December 13th. They issued a “peer perform” rating on the stock. UBS Group downgraded shares of Revvity from a “buy” rating to a “neutral” rating and upped their target price for the stock from $105.00 to $125.00 in a research note on Tuesday, January 16th. Finally, Wells Fargo & Company began coverage on shares of Revvity in a research note on Tuesday, December 19th. They issued an “equal weight” rating and a $95.00 target price on the stock. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $118.91.

Get Our Latest Research Report on Revvity

Insider Buying and Selling at Revvity

In other Revvity news, insider Prahlad R. Singh sold 21,217 shares of the company’s stock in a transaction that occurred on Monday, February 5th. The shares were sold at an average price of $104.28, for a total transaction of $2,212,508.76. Following the completion of the sale, the insider now directly owns 92,801 shares of the company’s stock, valued at $9,677,288.28. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.60% of the stock is owned by corporate insiders.

About Revvity

(Free Report)

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Recommended Stories

Institutional Ownership by Quarter for Revvity (NYSE:RVTY)

Receive News & Ratings for Revvity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revvity and related companies with MarketBeat.com's FREE daily email newsletter.